{"entity":{"type":"insider","cik":"0001252570","url":"/insider/0001252570","json_url":"/insider/0001252570.json","name":"BUZY PETER L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2003-09-15","last":"2019-05-30","span_basis":"filed_date"},"name_variants":[{"name":"BUZY PETER L","source":"filing","n_filings":4,"first_seen":"2003-09-15","last_seen":"2019-05-30"}],"transactions":[{"id":7958856,"accession":"0001596783-19-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001596783-19-000053","line_url":"/filing/0001596783-19-000053#line-1","is_derivative":false,"issuer_cik":"0001252570","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001252570","owner_cik":"0001252570","owner_name":"BUZY PETER L","owner_url":"/insider/0001252570","role":"Officer (President, Gene Therapy)","officer_title":"President, Gene Therapy","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44500.0,"shares_display":"44,500","price_per_share":45.13,"price_display":"45.13","price_state":"stated","total_value":2008285.0,"total_display":"2,008,285.00","shares_owned_after":44500.0,"shares_owned_after_display":"44,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-30","scope":"insider"},{"id":7748924,"accession":"0001209191-07-070616","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-070616","line_url":"/filing/0001209191-07-070616#line-2","is_derivative":false,"issuer_cik":"0000892025","issuer_name":"MARTEK BIOSCIENCES CORP","issuer_ticker":"MATK","issuer_name_source":null,"issuer_url":"/issuer/0000892025","owner_cik":"0001252570","owner_name":"BUZY PETER L","owner_url":"/insider/0001252570","role":"Officer (CFO, Treasurer and Exec VP)","officer_title":"CFO, Treasurer and Exec VP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":28.1225,"price_display":"28.12","price_state":"stated","total_value":1124900.0,"total_display":"1,124,900.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-18","filed_date":"2007-12-18","scope":"insider"},{"id":7324598,"accession":"0001209191-07-022617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-022617","line_url":"/filing/0001209191-07-022617#line-1","is_derivative":false,"issuer_cik":"0000892025","issuer_name":"MARTEK BIOSCIENCES CORP","issuer_ticker":"MATK","issuer_name_source":null,"issuer_url":"/issuer/0000892025","owner_cik":"0001252570","owner_name":"BUZY PETER L","owner_url":"/insider/0001252570","role":"Officer (CFO, Treasurer and Exec VP)","officer_title":"CFO, Treasurer and Exec VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3864.287,"shares_display":"3,864.29","price_per_share":21.22,"price_display":"21.22","price_state":"stated","total_value":82000.17014,"total_display":"82,000.17","shares_owned_after":3864.287,"shares_owned_after_display":"3,864.29","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-04","filed_date":"2007-04-05","scope":"insider"},{"id":64092,"accession":"0001209191-03-021674","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-03-021674","line_url":"/filing/0001209191-03-021674#line-5","is_derivative":false,"issuer_cik":"0000892025","issuer_name":"MARTEK BIOSCIENCES CORP","issuer_ticker":"MATK","issuer_name_source":null,"issuer_url":"/issuer/0000892025","owner_cik":"0001252570","owner_name":"BUZY PETER L","owner_url":"/insider/0001252570","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17082.0,"shares_display":"17,082","price_per_share":51.1482,"price_display":"51.15","price_state":"stated","total_value":873713.5524,"total_display":"873,713.55","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-09-15","filed_date":"2003-09-15","scope":"insider"},{"id":64091,"accession":"0001209191-03-021674","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-03-021674","line_url":"/filing/0001209191-03-021674#line-4","is_derivative":false,"issuer_cik":"0000892025","issuer_name":"MARTEK BIOSCIENCES CORP","issuer_ticker":"MATK","issuer_name_source":null,"issuer_url":"/issuer/0000892025","owner_cik":"0001252570","owner_name":"BUZY PETER L","owner_url":"/insider/0001252570","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8541.0,"shares_display":"8,541","price_per_share":51.8131,"price_display":"51.81","price_state":"stated","total_value":442535.6871,"total_display":"442,535.69","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-09-12","filed_date":"2003-09-15","scope":"insider"},{"id":64090,"accession":"0001209191-03-021674","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-03-021674","line_url":"/filing/0001209191-03-021674#line-3","is_derivative":false,"issuer_cik":"0000892025","issuer_name":"MARTEK BIOSCIENCES CORP","issuer_ticker":"MATK","issuer_name_source":null,"issuer_url":"/issuer/0000892025","owner_cik":"0001252570","owner_name":"BUZY PETER L","owner_url":"/insider/0001252570","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12377.0,"shares_display":"12,377","price_per_share":50.7756,"price_display":"50.78","price_state":"stated","total_value":628449.6012,"total_display":"628,449.60","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-09-11","filed_date":"2003-09-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001596783","name":"Catalent, Inc.","url":"/issuer/0001596783","role":"Officer (President, Gene Therapy)","n_filings":1,"first_seen":"2019-05-30","last_seen":"2019-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0000892025","name":"MARTEK BIOSCIENCES CORP","url":"/issuer/0000892025","role":"Officer (CFO, Treasurer and Exec VP)","n_filings":3,"first_seen":"2003-09-15","last_seen":"2007-12-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001252570","retrieved_at":"2026-08-22T04:24:56+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}